semaglutide and nonarteritic anterior ischemic optic neuropathy Risk of (NAION) in patients prescribed - Novo Nordisk Semaglutide Tied to Increased Risk

Common side effects include nausea, heartburn, and headaches

Retatrutide for Weight Loss: Benefits, GLP-3 Research & Teatment Options Retatrutide is an investigational once-weekly injection developed by Eli Lilly for obesity and related metabolic conditions

For people who are put off by needles, or who simply prefer the routine of a daily tablet, it offers the established effects of semaglutide in a needle free form

Focus on Protein-Rich Snacks : Including protein in your diet can help stabilize your blood sugar levels, which may reduce the likelihood of nausea

In a 2021 clinical trial of over 900 adults, about 80% of people with obesity lost 5% of their body weight after taking phentermine for 6 months

For context on adjacent metabolic research tools, the 5-Amino-1MQ Research Guide UK 2026: NNMT Inhibition & Metabolic Studies provides a complementary perspective on non-incretin metabolic pathways under active investigation